← Back to headlines
Amgen and AstraZeneca Drug Combo Shows Promise in Lung Cancer Trial
A combination therapy involving drugs from Amgen and AstraZeneca has been shown to extend survival rates in late-stage clinical trials for lung cancer patients.
8 Sept, 17:03 — 8 Sept, 17:03
Sources
Showing 1 of 1 sources
